Request Demo
Recent blog posts
Latest Hotspot
8 min read
NCT07410117 Cenvacibart Thrombosis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07410117 clinical trial report covering Cenvacibart, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07409428 HMPL-760 Diffuse large B-cell lymphoma recurrent Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07409428 clinical trial report covering HMPL-760, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07412236 Hydronidone Hepatitis B, Chronic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07412236 clinical trial report covering Hydronidone, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07412756 Brenipatide Depressive Disorder, Major Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07412756 clinical trial report covering Brenipatide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07416110 Human rabies vaccine (serum-free Vero cells)(Chengdu Biotec) Rabies Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07416110 clinical trial report covering Human rabies vaccine (serum-free Vero cells)(Chengdu Biotec), Phase 3, endpoints, sponsor, geography, readout ti
Latest Hotspot
8 min read
NCT07414706 Ropivacaine Hydrochloride Toxicity Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07414706 clinical trial report covering Ropivacaine Hydrochloride, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07414394 Tigulixostat Gout Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07414394 clinical trial report covering Tigulixostat, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07412613 Cadonilimab Microsatellite instability-high colorectal cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07412613 clinical trial report covering Cadonilimab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07415252 Herpes zoster vaccine (SK Chemicals) Chickenpox Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07415252 clinical trial report covering Herpes zoster vaccine (SK Chemicals), Phase 3, endpoints, sponsor, geography, readout timing and development whi
Latest Hotspot
8 min read
NCT07416994 YL-202 Locally Advanced Lung Non-Small Cell Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07416994 clinical trial report covering YL-202, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07418957 Lactobacillus double live bacteria for vagina(Guangdong Longchuangji Pharmaceuti Bacterial Vaginosis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07418957 clinical trial report covering Lactobacillus double live bacteria for vagina(Guangdong Longchuangji Pharmaceuti, Phase 3, endpoints, sponsor, g
Latest Hotspot
8 min read
NCT07417306 Poterepatide Diabetes Mellitus, Type 2 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
24 August 2026
NCT07417306 clinical trial report covering Poterepatide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.